SEC Tracker
Get the app

10-QOGN

Organon reports $1.57 billion revenue for Q3 2026

The company's condensed consolidated statements of income show that net income was $164 million for the quarter.1

By SEC Tracker ·

OrganonCIK 1821825Form 10-QFiled Oct 30, 2026, 8:03 AM ET0001821825-26-000004Read the filing on SEC.gov →

The company's condensed consolidated balance sheet as of September 30, 2026, shows total assets of $13.4 billion.2 Liabilities totaled $12.2 billion, and stockholders' equity was $1.193 billion.3

Organon & Co. disclosed in its Form 10-Q that it has trademarks for certain products, including those not available in the United States.4 Some trademarks are not owned by the company, such as Humira, Enbrel, and Remicade.5

Key facts

Company
Organon (OGN)
CIK
1821825
Form
10-Q
Filed
Oct 30, 2026, 8:03 AM ET
Accession
0001821825-26-000004

From the EDGAR filing index, not written by AI.

Organon results from its filings

Revenue, net income and cash as tagged in XBRL in the company's 10-Q and 10-K filings, up to this filing. Drawn in code; no figure here is written by AI.

Organon revenue and net income by quarterRevenueNet income$ billionsSource: XBRL in the company's 10-Q and 10-K filings, SEC EDGAR00.5011.52Revenue · Q1 FY25: 1.511.51Net income · Q1 FY25: 0.090.09Revenue · Q2 FY26: 1.561.56Net income · Q2 FY26: 0.110.11Revenue · Q3 FY26: 1.571.57Net income · Q3 FY26: 0.160.16Q1 FY25Q2 FY26Q3 FY26
Organon cash at period end$ billionsSource: XBRL in the company's 10-Q and 10-K filings, SEC EDGAR00.5011.51.46Q1 FY25Q2 FY26Q3 FY26Cash · Q1 FY25: 0.55Cash · Q2 FY26: 1.13Cash · Q3 FY26: 1.46
The numbers
PeriodRevenueNet incomeCashFiling
Q1 FY25$1.51B$0.09B$0.55B10-Q
Q2 FY26$1.56B$0.11B$1.13B10-Q
Q3 FY26$1.57B$0.16B$1.46B10-Q

How often Organon files

Filings per calendar quarter, counted in code from the company's EDGAR filing list. Each bar splits 8-K current reports from other forms; the last bar is the quarter of this filing, counted up to it.

Organon filings per quarter8-KOther formsSource: EDGAR filing list, counted in code010203040508-K · Q1 25: 2Other forms · Q1 25: 78-K · Q2 25: 4Other forms · Q2 25: 348-K · Q3 25: 1Other forms · Q3 25: 48-K · Q4 25: 4Other forms · Q4 25: 138-K · Q1 26: 2Other forms · Q1 26: 198-K · Q2 26: 3Other forms · Q2 26: 388-K · Q3 26: 3Other forms · Q3 26: 78-K · Q4 26: 1Other forms · Q4 26: 19385172141102Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Organon filings per quarter
The numbers
QuarterFilings8-K
Q1 2592
Q2 25384
Q3 2551
Q4 25174
Q1 26212
Q2 26413
Q3 26103
Q4 2621

Timeline

The company's filings on EDGAR around this one, newest first. Ownership forms and routine prospectus filings are left out.

  1. Form 10-QThis filing
  2. Form 8-K
  3. Form 8-K
  4. Form 10-Q
  5. Form 8-K
  6. Form DEFA14A

Get an email when Organon files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Written with AI from the Organon Form 10-Q and checked against it sentence by sentence: each of the 5 numbered sentences opens the passage it comes from. AI can make mistakes. Check the filing. Not investment advice. Not affiliated with the U.S. SEC. Source filing on SEC.gov.

Data on this page was fetched . The filing on SEC.gov is the record.